Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106893845 | 10689384 | 5 | F | 2014 | 20160819 | 20150105 | 20160826 | EXP | US-AMGEN-USASP2014102272 | AMGEN | 69.00 | YR | E | F | Y | 73.46000 | KG | 20160826 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106893845 | 10689384 | 1 | PS | PROLIA | DENOSUMAB | 1 | Unknown | UNK | 125320 | SOLUTION FOR INJECTION | |||||||||
| 106893845 | 10689384 | 2 | C | METOPROLOL. | METOPROLOL | 1 | 100 MG, QD | 0 | 100 | MG | QD | ||||||||
| 106893845 | 10689384 | 3 | C | VALSARTAN + HIDROCLOROTIAZIDA | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | QD | 0 | QD | ||||||||||
| 106893845 | 10689384 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 5 MG, QD | 0 | 5 | MG | QD | ||||||||
| 106893845 | 10689384 | 5 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 60 MG, UNK | 0 | 60 | MG | QD | ||||||||
| 106893845 | 10689384 | 6 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0.5 MG, QD | 0 | .5 | MG | QD | ||||||||
| 106893845 | 10689384 | 7 | C | ARMOUR THYROID | THYROID, PORCINE | 1 | 60 MG, QD | 0 | 60 | MG | QD | ||||||||
| 106893845 | 10689384 | 8 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | 50 MCG, QD | 0 | 50 | UG | QD | ||||||||
| 106893845 | 10689384 | 9 | C | TEKTURNA | ALISKIREN HEMIFUMARATE | 1 | Oral | 150 MG, UNK | 0 | 150 | MG | BID | |||||||
| 106893845 | 10689384 | 10 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 10 MG, UNK | 0 | 10 | MG | QD | ||||||||
| 106893845 | 10689384 | 11 | C | VITAMIN D2 | ERGOCALCIFEROL | 1 | Oral | 50000 UNIT, QWK | 0 | /wk | |||||||||
| 106893845 | 10689384 | 12 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | 1000 MCG/ML, Q2WK | 0 | QOW | ||||||||||
| 106893845 | 10689384 | 13 | C | CHLORDIAZEPOXIDE W/CLIDINIUM | 2 | Oral | UNK | 0 | |||||||||||
| 106893845 | 10689384 | 14 | C | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 106893845 | 10689384 | 15 | C | LASIX | FUROSEMIDE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 106893845 | 10689384 | 16 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | 100 MG, BID | 0 | 100 | MG | BID | ||||||||
| 106893845 | 10689384 | 17 | C | MYRBETRIQ | MIRABEGRON | 1 | UNK | 0 | |||||||||||
| 106893845 | 10689384 | 18 | C | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, QD | 0 | 200 | MG | QD | |||||||
| 106893845 | 10689384 | 19 | C | TYLENOL WITH CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Oral | UNK | 0 | ||||||||||
| 106893845 | 10689384 | 20 | C | LORTAB | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 325 MG | 0 | 325 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106893845 | 10689384 | 1 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106893845 | 10689384 | OT |
| 106893845 | 10689384 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106893845 | 10689384 | Activities of daily living impaired | |
| 106893845 | 10689384 | Anxiety | |
| 106893845 | 10689384 | Arthralgia | |
| 106893845 | 10689384 | Breast cancer recurrent | |
| 106893845 | 10689384 | Depression | |
| 106893845 | 10689384 | Femur fracture | |
| 106893845 | 10689384 | Gait disturbance | |
| 106893845 | 10689384 | Muscular weakness | |
| 106893845 | 10689384 | Osteonecrosis | |
| 106893845 | 10689384 | Pain in extremity | |
| 106893845 | 10689384 | Pathological fracture | |
| 106893845 | 10689384 | Sleep disorder due to a general medical condition | |
| 106893845 | 10689384 | Stress fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106893845 | 10689384 | 1 | 2012 | 0 |